Trevi Therapeutics (TRVI) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 103.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.38% |
| Dec 31, 2025 | -310.34% |
| Sep 30, 2025 | -2,048.49% |
| Jun 30, 2025 | 11,619.34% |
| Mar 31, 2025 | 20.78% |
| Dec 31, 2024 | 180.55% |
| Sep 30, 2024 | -74.71% |
| Jun 30, 2024 | -140.36% |
| Mar 31, 2024 | -1,881.45% |
| Dec 31, 2023 | 111.91% |
| Sep 30, 2023 | -70.84% |
| Jun 30, 2023 | -95.78% |
| Mar 31, 2023 | 87.85% |
| Dec 31, 2022 | -818.65% |
| Sep 30, 2022 | 689.22% |
| Jun 30, 2022 | 1,067.97% |
| Mar 31, 2022 | -124.92% |
| Dec 31, 2021 | 190.59% |
| Sep 30, 2021 | -177.99% |
| Jun 30, 2021 | 39.01% |
| Mar 31, 2021 | 26.58% |
| Dec 31, 2020 | -33.70% |
| Sep 30, 2020 | 215.76% |
| Jun 30, 2020 | -114.44% |
| Mar 31, 2020 | -181.35% |
| Dec 31, 2019 | 2.05% |
| Sep 30, 2019 | -221.56% |
| Jun 30, 2019 | 756.57% |
| Mar 31, 2019 | 194.77% |